Hassman Research Institute   Report issue

For profit Phase 4
Founded: Berlin NJ United States (2016)
Status: Acquired by Apex Innovative Sciences, Inc. (2019)

Organization Overview

First Clinical Trial
2019
NCT03993392
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Hassman Research Institute